Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study of Gaboxadol in Primary Insomnia
This study has been completed.
Study NCT00209924   Information provided by H. Lundbeck A/S

First Received on September 13, 2005.   Last Updated on March 29, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Primary Insomnia
Additional conditions recognized in this trial
Sleep Initiation and Maintenance Disorders
More general conditions related to this trial
Dyssomnias
Mental Disorders
Nervous System Diseases
Sleep Disorders
Sleep Disorders, Intrinsic
Interventions listed in this trial
Gaboxadol
Additional drug interventions recognized in this trial
4,5,6,7-tetrahydroisoxazolo(5,4-c)pyridin-3-ol
More general drug interventions related to this trial
Analgesics
Anticonvulsants
Central Nervous System Agents
GABA Agents
GABA Agonists
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
H. Lundbeck A/S


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services